Your browser doesn't support javascript.
loading
How do I: Evaluate the safety and legitimacy of unproven cellular therapies?
Guleria, Indira; de Los Angeles Muñiz, Maria; Wilgo, Matthew; Bapat, Asawari; Cui, Wanxing; Hsu, Yen-Michael Sheng; Jeyaraman, Madhan; Muthu, Sathish; Rodriguez, Federico; Fesnak, Andrew; Celluzzi, Christina; Sesok-Pizzini, Deborah; Reich-Slotky, Ronit; Spitzer, Thomas.
Affiliation
  • Guleria I; Renal Transplant Program, Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • de Los Angeles Muñiz M; Harvard Medical School, Boston, Massachusetts, USA.
  • Wilgo M; Transfusion Medicine and Cellular Therapy Division, Department of Pathology, Weill Cornell Medicine, New York, New York, USA.
  • Bapat A; New England Cord Blood Bank, Inc., New England Cryogenic Center. Inc., Marlborough, Massachusetts, USA.
  • Cui W; Department of Quality and Regulatory Affairs, Infohealth FZE and Questar Enterprises, Dubai, UAE.
  • Hsu YS; Cell Therapy Manufacturing Facility, Department of Pathology and Laboratory Medicine, MedStar Georgetown University Hospital, Gerorgetown, Washington, District of Columbia, USA.
  • Jeyaraman M; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
  • Muthu S; Department of Orthopaedics, Faculty of Medicine, Sri Lalithambigai Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai, India.
  • Rodriguez F; Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India.
  • Fesnak A; Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India.
  • Celluzzi C; Department of Orthopaedics, Government Medical College and Hospital, Dindigul, India.
  • Sesok-Pizzini D; Collections and Processing Facility, Bone Marrow Transplant Program, UF Health Shands Cancer Hospital, Gainsville, Florida, USA.
  • Reich-Slotky R; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Spitzer T; Department of Biotherapies, Association for the Advancement of Blood and Biotherapies, Bethesda, Maryland, USA.
Transfusion ; 62(3): 518-532, 2022 03.
Article in En | MEDLINE | ID: mdl-35143051
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Cell- and Tissue-Based Therapy Limits: Humans Language: En Journal: Transfusion Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Cell- and Tissue-Based Therapy Limits: Humans Language: En Journal: Transfusion Year: 2022 Type: Article Affiliation country: United States